Ancillary Observational Study of Post-Frontline Sequential Treatment of Adult Philadelphia Chromosome-Positive (Ph+) Acute Lymphoblastic Leukemia (ALL) Patients With Dasatinib and the Bispecific Monoclonal Antibody Blinatumomab
Not yet recruiting
Phase of Trial: Phase IV
Latest Information Update: 22 Oct 2018
At a glance
- Drugs Blinatumomab (Primary) ; Dasatinib (Primary)
- Indications Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Therapeutic Use
- 12 Oct 2018 Planned initiation date changed from 1 Sep 2018 to 1 Dec 2018.
- 31 Aug 2018 Biomarkers information updated
- 03 Aug 2018 Planned initiation date changed from 1 Mar 2018 to 1 Sep 2018.